​

iBio (IBIO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

IBIO Stock Forecast

iBio (IBIO) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $5.00, with a high of $5.00 and a low of $5.00. This represents a 316.67% increase from the last price of $1.20.

- $1 $2 $3 $4 $5 $6 High: $5 Avg: $5 Low: $5 Last Closed Price: $1.2

IBIO Stock Rating

iBio stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 1 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 3 Strong Sell Sell Hold Buy Strong Buy

IBIO Price Target Upside V Benchmarks

TypeNameUpside
StockiBio316.67%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$3.50
Last Closing Price$1.20$1.20$1.20
Upside/Downside--191.67%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 2617---8
Aug, 2617---8
Jul, 2617---8
Jun, 26-6---6
May, 26-6---6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 08, 2026Raymond James$5.00$1.82174.73%316.67%
Oct 17, 2025Roanna RuizLeerink Partners$2.00$0.85135.29%66.67%
Jul 22, 2024Kemp DolliverLoop Capital Markets$3.60$2.2162.90%200.00%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 17, 2026H.C. WainwrightBuyinitialise
Jun 08, 2026Raymond JamesOutperforminitialise
Oct 29, 2025OppenheimerOutperformOutperformhold
Jul 22, 2024Brookline CapitalBuyinitialise
May 28, 2024Chardan CapitalBuyinitialise
Oct 06, 2022Cantor FitzgeraldNeutralupgrade

Financial Forecast

EPS Forecast

$-3K $-2K $-2K $-1K $-600 $0 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$-2.89K$-106.18$-6.50$-1.75$-0.32---
Avg Forecast$-105.00$-111.40$-7.41$-1.59$-1.38$-0.67$-0.74$-0.76
High Forecast$-105.00$-53.47$-0.60$-0.76$-0.66$-0.32$-0.36$-0.36
Low Forecast$-105.00$-227.26$-14.22$-3.24$-2.81$-1.37$-1.51$-1.55
Surprise %2651.49%-4.69%-12.28%10.06%-76.81%---

Revenue Forecast

$0 $9M $18M $27M $36M $45M Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$1.88M-$225.00K$400.00K$100.00K---
Avg Forecast$2.55M$500.00K$25.00K$300.00K$800.00K$8.00M$24.00M$78.71K
High Forecast$2.55M$900.01K$45.00K$540.00K$1.44M$14.40M$43.20M$141.67K
Low Forecast$2.55M$300.00K$15.00K$180.00K$480.00K$4.80M$14.40M$47.22K
Surprise %-26.12%-800.00%33.33%-87.50%---

Net Income Forecast

$-900M $-720M $-540M $-360M $-180M $0 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$-50.39M$-65.01M$-24.91M$-18.38M$-33.04M---
Avg Forecast$-402.34M$-426.77M$-28.39M$-6.09M$-6.64M$-3.23M$-2.83M$-2.91M
High Forecast$-402.34M$-204.85M$-2.30M$-2.92M$-2.53M$-1.23M$-1.36M$-1.40M
Low Forecast$-402.34M$-870.63M$-54.47M$-12.43M$-10.75M$-5.24M$-5.78M$-5.94M
Surprise %-87.48%-84.77%-12.26%201.69%397.85%---

IBIO Forecast FAQ

Is iBio stock a buy?

iBio stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that iBio is a favorable investment for most analysts.

What is iBio's price target?

iBio's price target, set by 4 Wall Street analysts, averages $5 over the next 12 months. The price target range spans from $5 at the low end to $5 at the high end, suggesting a potential 316.67% change from the previous closing price of $1.2.

How does iBio stock forecast compare to its benchmarks?

iBio's stock forecast shows a 316.67% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for iBio over the past three months?

  • September 2026: 12.50% Strong Buy, 87.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 12.50% Strong Buy, 87.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 12.50% Strong Buy, 87.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is iBio’s EPS forecast?

iBio's average annual EPS forecast for its fiscal year ending in June 2027 is $-0.67, marking a 109.38% increase from the reported $-0.32 in 2026. Estimates for the following years are $-0.74 in 2028, and $-0.76 in 2029.

What is iBio’s revenue forecast?

iBio's average annual revenue forecast for its fiscal year ending in June 2027 is $8M, reflecting a 7900.00% increase from the reported $100K in 2026. The forecast for 2028 is $24M, and $78.71K for 2029.

What is iBio’s net income forecast?

iBio's net income forecast for the fiscal year ending in June 2027 stands at $-3.234M, representing a -90.21% decrease from the reported $-33.044M in 2026. Projections indicate $-2.835M in 2028, and $-2.912M in 2029.